Press Releases | Medtronic

Month Year

Email alerts

Mar 14, 2010

Medtronic's Endeavor Stent Continues to Demonstrate Compelling and Consistent Long-Term Clinical Results

Independent Analysis of Large and Comprehensive ENDEAVOR Program Shows Remarkably Durable Safety and Efficacy at Five Years of Follow Up in Coronary Artery Disease Patients

MINNEAPOLIS & ALTANTA, Mar 14, 2010 (BUSINESS WIRE) -- The consistency and quality of the long-term clinical results for the Endeavor(R) drug-eluting stent (DES) from Medtronic, Inc. (NYSE: MDT),...
Mar 12, 2010

Medtronic Starts International Study of CoreValve(R) Transcatheter Aortic Valve System

Post-Market Evaluation of Breakthrough Medical Device Begins Enrolling Patients; First Implants Occur in Germany

MINNEAPOLIS, Mar 12, 2010 (BUSINESS WIRE) -- Moving to expand the evidence base for the future of structural heart disease therapy,Medtronic, Inc. (NYSE: MDT), today announced the start of the...
Mar 12, 2010

FDA Panel Recommends Approval with Conditions of Medtronic Deep Brain Stimulation Therapy for Patients with Refractory Epilepsy

MINNEAPOLIS, Mar 12, 2010 (BUSINESS WIRE) -- The U.S. Food and Drug Administration (FDA) Neurological Devices Panel today voted seven to five to recommend approval with conditions of Deep Brain...
Mar 11, 2010

Medtronic Announces Public Offering of Senior Notes

MINNEAPOLIS, Mar 11, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced a registered offering of $1.25 billion of its 3.0 percent Senior Notes due 2015, $1.25 billion of its 4.45...
Mar 10, 2010

Medtronic Introduces the VERTEX SELECT(R) Reconstruction System

Offering Surgeons the Next Generation of Occipitocervical Upper-Thoracic Fixation

MEMPHIS, Tenn., Mar 10, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced the U.S. launch of the VERTEX SELECT(R) Reconstruction System. When a patient has a spinal condition...
Mar 9, 2010

William A. Hawkins, Medtronic Chairman and CEO, Receives Distinguished Achievement Award from Biomedical Engineering Society

Lecture Published by Annals of Biomedical Engineering

MINNEAPOLIS, Mar 09, 2010 (BUSINESS WIRE) -- Medtronic, Inc., (NYSE: MDT), today announced William A. Hawkins, chairman and CEO, recently received the Biomedical Engineering Society's...
Mar 4, 2010

Medtronic Named Among World's Most Innovative Companies by MIT Technology Review

Company Recognized for Ground-Breaking Work in the Field of Deep Brain Stimulation Medtronic, Inc. (NYSE: MDT) today announced that it has been selected as one of Massachusetts Institute of Technology
Mar 3, 2010

Medtronic Recognized for Excellence in Corporate Citizenship

Corporate Responsibility Magazine lists Medtronic among 2010's 100 Best Corporate Citizens

NEW YORK, Mar 03, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) was named today to the 11th annual "100 Best Corporate Citizens List" published by Corporate Responsibility magazine (formerly...
Mar 2, 2010

Medtronic CFO Gary Ellis to Speak at the Cowen & Company Health Care Conference

MINNEAPOLIS, Mar 02, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT), today announced it will participate in the 30th Annual Cowen and Company Health Care Conference on Tuesday, March 9, 2010,...
Feb 23, 2010

Medtronic Third Quarter Revenue Increases 10% to $3.851 Billion; Raises Lower End of EPS Guidance for Current Fiscal Year

Non-GAAP diluted EPS of $0.77 grew 8%; GAAP diluted EPS of $0.75 grew 21%International revenue of $1.615 billion grew 11% on a constant currency basis; 22% as reportedFree cash flow exceeds $1.3 billion; GAAP cash flow from operations of $1.488 billionWorldwide ICD revenue growth of 5% on a constant currency basis; 9% as reportedWorldwide CardioVascular revenue growth of 21% on a constant currency basis; 28% as reported

MINNEAPOLIS, Feb 23, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today reported financial results for the third quarter of fiscal year 2010, which ended January 29, 2010. The company...

Show per page